Since HOXA-AS2 could target multiple miRNAs or mRNAs, more clinical and experimental studies needed to be performed to further investigate molecular mechanism of HOXA-AS2 in NSCLC. The gene discussed is HOXA-AS2; the disease is non-small cell lung carcinoma.